Viewing Study NCT04575467


Ignite Creation Date: 2025-12-25 @ 12:54 AM
Ignite Modification Date: 2026-01-01 @ 7:09 PM
Study NCT ID: NCT04575467
Status: COMPLETED
Last Update Posted: 2024-08-09
First Post: 2020-08-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1)
Sponsor: Caliway Biopharmaceuticals Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-12-09
Start Date Type: ACTUAL
Primary Completion Date: 2021-11-15
Primary Completion Date Type: ACTUAL
Completion Date: 2021-12-08
Completion Date Type: ACTUAL
First Submit Date: 2020-08-19
First Submit QC Date: None
Study First Post Date: 2020-10-05
Study First Post Date Type: ACTUAL
Results First Submit Date: 2024-02-22
Results First Submit QC Date: None
Results First Post Date: 2024-03-28
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-07-16
Last Update Post Date: 2024-08-09
Last Update Post Date Type: ACTUAL